← Research library

Chelohart: clinical report on a tissue-derived preparation

Comparison in people · 2011

What was studied
32 angina patients: 22 adjunctive Chelohart; 10 controls.
Main finding
Angina occurred during exercise testing in 36.4% with Chelohart and 50% with conventional care. Threshold exercise power did not differ significantly between groups.

Angina during cycle ergometry · 36.4% with Chelohart versus 50% with conventional care. Shared baseline 68.8%. · The report marks p < 0.05 versus conventional care.

Reported findings and study design

22 adults received one Chelohart capsule twice daily with meals for 30 days alongside conventional care. Ten controls received conventional therapy alone.

Population or model 32 angina patients: 22 adjunctive Chelohart; 10 controls.

Results · Medical Center report, PDF pages 84–85, Table 3
MeasureResultComparison, timing and statistics
Angina during cycle ergometry36.4% with Chelohart versus 50% with conventional care. Shared baseline 68.8%.The report marks p < 0.05 versus conventional care.
Achieving submaximal heart rate54.5% versus 40%. Shared baseline 21.9%.The report marks p < 0.05 versus conventional care.
Threshold exercise power119.3 ± 4.6 versus 115.2 ± 5.4 in the report’s stated units.The text reports a nonsignificant between-group difference.

The report leaves allocation and masking unspecified and gives a shared baseline for the exercise table.

Source for these results ↗ · Reviewed 2026-11-16

Study limitations and source details

Study limitations

  • A larger numerical improvement is not necessarily a significant between-group difference. Allocation, blinding and complete adverse-event collection need verification from original study documentation.
  • Commercially reproduced institute report; independent peer review and independent replication are not established by this document.
  • Short-term reporting without a complete adverse-event protocol cannot establish long-term safety. Preparation equivalence to current products or synthetic peptides is unproven.

Source details

Institute report — commercial reproduction

Russian report reproduced on a commercial website; population, comparison and reported outcomes checked. Signed original and full protocol not authenticated.

Sources checked

Citation

Report attributed to · Medical Center, St. Petersburg Institute of Bioregulation and Gerontology

Human comparative studyFull text available

St. Petersburg Institute of Bioregulation and Gerontology Medical Center (report attribution). Chelohart: clinical report on a tissue-derived preparation Institute clinical report (commercial reproduction); 2011 study/report date, not website publication date

Study source ↗ · Bibliography entry · Link to this summary

Related compounds

Editorial policy and evidence standards